Robert Clark
Directeur/Membre du Conseil chez INCANNEX HEALTHCARE INC.
Fortune : 230 000 $ au 30/04/2024
Profil
Robert Bruce Clark currently works at Incannex Healthcare, Inc., as Independent Non-Executive Director from 2022 and Novo Nordisk, Inc., as Vice President-Regulatory Affairs from 2012.
Mr. Clark also formerly worked at Pfizer Inc., as Head-United States Regulatory Strategy from 1992 to 2021.
Mr. Clark received his graduate degree from New York Medical College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
0,63% | 21/12/2023 | 100 000 ( 0,63% ) | 230 000 $ | 30/04/2024 |
Postes actifs de Robert Clark
| Sociétés | Poste | Début |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Directeur/Membre du Conseil | 17/08/2022 |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Conseiller Juridique Général | 01/01/2012 |
Anciens postes connus de Robert Clark
| Sociétés | Poste | Fin |
|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 01/01/2021 |
Formation de Robert Clark
| New York Medical College | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| INCANNEX HEALTHCARE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |